Sort   by:  
 Page size 
ProteomicsProtein modifications by advanced glycation end products (AGEs) in human clear cell renal cell carcinoma
The development of clear cell renal cell carcinoma (ccRCC) is connected with disturbed glycolytic processes leading to the highly reactive dicarbonyls generation, resulting in protein modifications by advanced glycation end products (AGEs). Therefore, the present study aimed to analyze the level of ...
ORGANISM(S): Homo sapiens (Human) 
2026-02-09 | PXD059009 | Pride
Advanced glycation end products (ages)  protein modification  proteomics  kidney disease  tumor  clear cell renal cell carcinoma (ccrcc) 
ProteomicsAdvanced glycation end products as markers of ageing in plants: glycation hotspots in the plant proteome
Glycation is a post-translational modification underlied by the interaction of protein amino and guanidino groups with carbonyl compounds like reducing sugars and α-dicarbonyls. In the first steps of this process, the protein amino groups react with reducing carbohydrates yielding the corresponding ...
ORGANISM(S): Arabidopsis thaliana (Mouse-ear cress) 
2017-06-19 | PXD006434 | Pride
Ages Plant proteomics Glycation 
ProteomicsGlmS plays a key role in the virulence and biofilm formation ability of Staphylococcus aureus promoted by advanced glycation end products
Staphylococcus aureus (S. aureus) is well known for its biofilm formation ability and is responsible for serious, chronic refractory infections worldwide. We previously demonstrated that advanced glycation end products (AGEs), a hallmark of chronic hyperglycemia in diabetic tissues, enhanced biofilm...
ORGANISM(S): Staphylococcus aureus 
2024-05-22 | PXD046076 | Pride
Staphylococcus aureus  advanced glycation end products  biofilm formation  glms-sigb regulatory axis 
ProteomicsGlyceraldehyde treatment on pancreatic ductal epithelial cells
To study the impact of the accumulation of glyceraldehyde-derived intracellular protein advanced glycation end products (AGEs) on global proteomic changes in pancreatic ductal epithelial cells. The cells were treated with glyceraldehyde for up to 2 days and changes of protein expressions were assess...
ORGANISM(S): Homo sapiens (Human) 
2025-07-21 | PXD050491 | Pride
Glycation Glyceraldehyde Advanced glcation end products (ages) Epethelial cells 
ProteomicsCooking methods affect Advanced Glycation End products and lipid profiles: a randomized cross-over study in healthy subjects
Thermal treatments used in Ultra-Processed Foods (UPFs) lead to advanced glycation end products (AGEs) in food products. UPFs and serum AGEs are both associated with cardiometabolic disease. We explored differential cooking methods as a mechanistic link between UPFs and detrimental health outcomes. ...
ORGANISM(S): Homo sapiens (Human) 
2025-01-24 | PXD059624 | Pride
Human Diet Olink 
TranscriptomicsPlatelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor
Platelets contain abundant miRNAs, however, the biogenesis pathway of miRNAs in anucleate platelets is unclear. Platelet-rich plasma was diluted in washing buffer and the platelet suspension was centrifuged to isolated pure platelets.Finally, platelets were recovered in suspension buffer at the conc...
ORGANISM(S): Homo sapiens 
2014-02-04 | E-GEOD-51453 | biostudies-arrayexpress
TranscriptomicsTranscriptome analysis of Advanced glycation end products treated ligament cells
Ossification of the posterior longitudinal ligament (OPLL) is formed by heterogeneous ossification of posterior longitudinal ligament. The patho-mechanism of OPLL is still largely unknown. Recently, disorders of metabolism are thought to be the center of many diseases such as OPLL. Advanced glycati...
ORGANISM(S): Homo sapiens 
2016-02-16 | E-GEOD-65952 | biostudies-arrayexpress
GenomicsDescriptive Transcriptome Analysis of Tendon Derived Fibroblasts Following In-Vitro Exposure to Advanced Glycation End Products
Descriptive Transcriptome Analysis of Tendon Derived Fibroblasts Following In-Vitro Exposure to Advanced Glycation End Products
PRJNA842004 | ENA
GenomicsEffect of advanced glycation end products on endometrial receptivity in patients with polycystic ovary syndrome
Effect of advanced glycation end products on endometrial receptivity in patients with polycystic ovary syndrome
PRJNA1158474 | ENA
UnknownAdvanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs.
Not available
S-EPMC4904211 | biostudies-literature
Sort   by:  
 Page size